GlaxoSmithKline Closes Plant After Discovering Legionnaire's Bacteria

GlaxoSmithKline (NYSE:GSK) closed a plant that manufactures inhaled medications after discovering bacteria that causes the potentially fatal form of pneumonia, Legionnaire’s disease.
According to an article from Pharma Pro:

The manufacturing plant in Zebulon, about 25 miles east of Raleigh, was closed after routine testing found the bacteria in a self-standing cooling tower. About 400 of the 850 employees who work in Zebulon were told to stay away until the towers are cleaned, officials for the London-based company said.
The Food and Drug Administration was checking into reports of the bacteria’s discovery and a spokesman said all questions should be directed to GlaxoSmithKline. State and county health officials said they were not aware of any Legionnaire’s disease cases associated with the Glaxo facility, adding that most people who are exposed to the bacteria do not become ill.

 
Click here to read the full article on Pharma Pro.